Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Increasing your income can significantly aid in debt repayment. Discover various ways to boost your earnings and pay off debt.
27,939 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Geopolitics can swing oil prices quickly. If Iran talks progress, the market could move fast. This guide shows practi...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
As toyota's challenging u.s. business tests the automaker, investors watch for strategies that could yield a Maverick...
AI data centers are sparking a sweeping power expansion in the U.S. Three utility ETFs offer distinct routes to ride ...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...
A deep dive into a sleeper AI infrastructure stock that could gain as data centers demand faster, cleaner connectivit...
Longbridge Financial and Friday Harbor unveiled a joint AI pre-underwriting platform designed to flag issues early in...
July has brought headlines that test investors' nerves. This piece breaks down what drove stock moves today, what Luc...
A fresh look at why sandisk stock still has upside in a volatile market. This piece breaks down three durable drivers...
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
Gulf sovereign wealth funds accelerate dealmaking in 2026, defying fears that the Iran conflict would curb appetite f...